跳至主要内容
临床试验/NCT02936232
NCT02936232招募中不适用

Severe Sepsis and Septic Shock Registry

Seoul National University Hospital3 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
3
主要终点
28-day mortality

研究概览

简要总结

The aim of this study is to construct multi-center sepsis registry that can be used for data warehousing and clinical research.

详细描述

This registry prospectively enrolls adult patients with severe sepsis or septic shock in 21 tertiary hospital emergency departments.

Registered data can be used for quality control and clinical research to reduce sepsis-related mortality.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • two of more systemic inflammatory reaction syndrome criteria fever > 38.3 'C or hypothermia < 36'C, tachycardia over 90 bpm tachypnea over 20 per minute, leukocytosis (WBC over 12k/microL) or leukopenia (WBC below 4k/microL)
  • suspected or proven infection
  • any organ dysfunction as follows:
  • cardiovascular (hypotension, systolic blood pressure <90 mmHg, mean arterial pressure <70mmHg)
  • tissue hypoperfusion (lactate above upper limits laboratory normal)
  • acute lung injury (PaO2/inspired oxygen fraction < 250 in the absence of pneumonia, PaO2/inspired oxygen fraction < 200 in the presence of pneumonia)
  • acute kidney injury (Urine output < 0.5mL/kg/hr for at least 2 hrs Serum creatinine > 2.0 mg/dL)
  • acute liver injury (Total bilirubin > 2mg/dL)
  • acute coagulopathy (Platelet count < 100,000/μL or prothrombin time, international normalized ratio > 1.5)

排除标准

  • age less than 18 years old
  • patients with cardiac arrest at presentation
  • patients with advanced directives not to deliver aggressive organ supportive management

结局指标

主要结局

28-day mortality

时间窗: 28-day

According to hospital discharge record review and telephone follow-up.

次要结局

  • ICU length of stay(hospital discharge (non-survivors) or 90 days (survivors))
  • Organ support treatment (mechanical ventilation)(hospital discharge (non-survivors) or 90 days (survivors))
  • Hospital length of stay(hospital discharge (non-survivors) or 90 days (survivors))
  • 90-day mortality(90-day)
  • Organ support treatment (renal replacement therapy)(hospital discharge (non-survivors) or 90 days (survivors))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gil Joon Suh

Professor

Seoul National University Hospital

研究点 (3)

Loading locations...

相似试验

Severe Sepsis and Septic Shock Registry | 临床试验